Fintepla 유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

fintepla

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

DUOKOPT (JOZ) Augndropar, lausn 20 mg/ml + 5 mg/ml 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

duokopt (joz) augndropar, lausn 20 mg/ml + 5 mg/ml

laboratoires thea s.a.s. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml + 5 mg/ml

Cosopt sine Augndropar, lausn 20 mg/ml+5 mg/ml 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

cosopt sine augndropar, lausn 20 mg/ml+5 mg/ml

santen oy* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml+5 mg/ml

Dorzolamide/Timolol Alvogen Augndropar, lausn 20mg/ml+5 mg/ml 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

dorzolamide/timolol alvogen augndropar, lausn 20mg/ml+5 mg/ml

alvogen ehf. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20mg/ml+5 mg/ml